Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.27 | 0.40 | -33.08 |
| EPS, GAAP | 0.26 | 0.40 | 0.40 |
| Consensus Estimate | 0.40 | 0.40 | 1.54 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.75 | 1.44 | 21.20 |
| EPS, GAAP | 1.68 | 1.39 | 20.68 |
| Consensus Estimate | 1.42 | 1.36 | 4.44 |
| VPHM | Industry Average | |
| P/E (TTM) | 13.79 | NA |
| P/E (Forward) | 35.50 | NA |
| PEG Ratio | 11.93 | 2.17 |
| Price/Sales | 2.53 | 4.18 |
| Beta | 1.03 | 0.62 |
| 5/1/2012 | Stocks to Watch: PLX Tech, PF Chang's, Sears Holdings (WSJ.com) |
| 4/16/2012 | Charting the Market (Barrons.com) |
| 4/10/2012 | Stocks in the Spotlight Tuesday (Barrons.com) |
| 4/10/2012 | Tuesday’s biggest gaining and declining stocks (MarketWatch.com) |
| 4/10/2012 | Stocks To Watch: ViroPharma, Supervalu, Sony (WSJ.com) |
| 4/10/2012 | VioPharma Runs Into FDA & FTC Troubles Over Staph Drug (VPHM) (24/7 Wall St) |
| 3/23/2012 | Don't just ask, "How much inventory?" Ask, "What kind?" (The Motley Fool) |
| 2/29/2012 | Just the facts, Fool. (The Motley Fool) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
